Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| nef Gene Products, Human Immunodeficiency Virus | 4 | 2021 | 59 | 2.250 |
Why?
|
| Astrocytes | 8 | 2021 | 244 | 1.710 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 13 | 2013 | 57 | 1.600 |
Why?
|
| Simian immunodeficiency virus | 13 | 2013 | 60 | 1.360 |
Why?
|
| Morphine Dependence | 9 | 2010 | 23 | 1.170 |
Why?
|
| Blood-Brain Barrier | 2 | 2021 | 173 | 1.170 |
Why?
|
| Hippocampus | 3 | 2019 | 594 | 1.100 |
Why?
|
| Evolution, Molecular | 8 | 2009 | 307 | 0.990 |
Why?
|
| Memory Disorders | 2 | 2014 | 77 | 0.770 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2021 | 54 | 0.710 |
Why?
|
| Neurons | 3 | 2019 | 1263 | 0.670 |
Why?
|
| Chemokine CCL2 | 2 | 2019 | 95 | 0.660 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2019 | 13 | 0.630 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 3 | 2014 | 8 | 0.590 |
Why?
|
| HIV-1 | 9 | 2021 | 755 | 0.550 |
Why?
|
| Brain | 4 | 2021 | 1472 | 0.540 |
Why?
|
| Genes, tat | 2 | 2006 | 8 | 0.490 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2021 | 1766 | 0.480 |
Why?
|
| Cells, Cultured | 4 | 2021 | 1621 | 0.440 |
Why?
|
| Disease Progression | 10 | 2013 | 667 | 0.440 |
Why?
|
| Macaca mulatta | 7 | 2013 | 139 | 0.430 |
Why?
|
| Macaca | 6 | 2009 | 36 | 0.390 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 2009 | 226 | 0.390 |
Why?
|
| Synapses | 1 | 2014 | 185 | 0.380 |
Why?
|
| Animals | 21 | 2021 | 16992 | 0.360 |
Why?
|
| Gene Products, vpr | 2 | 2013 | 5 | 0.360 |
Why?
|
| Rats | 4 | 2021 | 3735 | 0.340 |
Why?
|
| Lac Operon | 3 | 2000 | 21 | 0.340 |
Why?
|
| Interleukin-1beta | 2 | 2021 | 75 | 0.330 |
Why?
|
| DNA-Directed RNA Polymerases | 3 | 2000 | 22 | 0.310 |
Why?
|
| Biomedical Research | 3 | 2021 | 502 | 0.290 |
Why?
|
| Molecular Sequence Data | 10 | 2009 | 1542 | 0.290 |
Why?
|
| Narcotics | 1 | 2008 | 29 | 0.280 |
Why?
|
| Primates | 1 | 2008 | 39 | 0.280 |
Why?
|
| Immune System | 1 | 2008 | 41 | 0.280 |
Why?
|
| Transcription, Genetic | 3 | 2000 | 592 | 0.270 |
Why?
|
| Disease Models, Animal | 7 | 2014 | 1596 | 0.260 |
Why?
|
| Phylogeny | 4 | 2006 | 769 | 0.260 |
Why?
|
| Male | 12 | 2021 | 23409 | 0.250 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 3 | 2013 | 55 | 0.250 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2006 | 9 | 0.250 |
Why?
|
| Virus Replication | 2 | 2005 | 318 | 0.250 |
Why?
|
| Cerebrospinal Fluid | 1 | 2006 | 20 | 0.240 |
Why?
|
| Esophagitis | 1 | 2006 | 7 | 0.240 |
Why?
|
| Eosinophilia | 1 | 2006 | 17 | 0.240 |
Why?
|
| Gastroesophageal Reflux | 1 | 2006 | 37 | 0.240 |
Why?
|
| Gene Products, env | 3 | 2012 | 23 | 0.240 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2006 | 129 | 0.230 |
Why?
|
| Morphine | 3 | 2013 | 69 | 0.220 |
Why?
|
| Minority Groups | 2 | 2021 | 690 | 0.210 |
Why?
|
| Gene Products, pol | 1 | 2003 | 2 | 0.210 |
Why?
|
| Transfection | 3 | 2014 | 532 | 0.210 |
Why?
|
| Chemokine CCL5 | 2 | 2013 | 41 | 0.200 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 209 | 0.190 |
Why?
|
| Macrophages | 2 | 2019 | 529 | 0.180 |
Why?
|
| Propranolol | 1 | 2021 | 18 | 0.180 |
Why?
|
| Intestine, Small | 1 | 2021 | 25 | 0.180 |
Why?
|
| HIV Infections | 5 | 2012 | 2586 | 0.180 |
Why?
|
| Amino Acid Sequence | 5 | 2009 | 1180 | 0.180 |
Why?
|
| Students | 2 | 2018 | 626 | 0.170 |
Why?
|
| Pteridines | 1 | 2019 | 3 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 2 | 2000 | 526 | 0.160 |
Why?
|
| Viral Envelope Proteins | 2 | 2012 | 91 | 0.160 |
Why?
|
| Mutation, Missense | 2 | 2013 | 91 | 0.160 |
Why?
|
| Down-Regulation | 1 | 2021 | 456 | 0.160 |
Why?
|
| Drug Resistance, Viral | 3 | 2004 | 67 | 0.150 |
Why?
|
| NF-kappa B | 2 | 2013 | 358 | 0.150 |
Why?
|
| Coculture Techniques | 1 | 2019 | 109 | 0.150 |
Why?
|
| Cyclic AMP Receptor Protein | 1 | 1998 | 1 | 0.150 |
Why?
|
| Behavioral Research | 1 | 2019 | 41 | 0.140 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1271 | 0.140 |
Why?
|
| Physiology | 1 | 2018 | 17 | 0.140 |
Why?
|
| Lung | 1 | 2021 | 492 | 0.140 |
Why?
|
| Escherichia coli | 2 | 1998 | 460 | 0.140 |
Why?
|
| Professional Role | 1 | 2018 | 40 | 0.140 |
Why?
|
| Minority Health | 1 | 2019 | 95 | 0.140 |
Why?
|
| Thinking | 1 | 2018 | 37 | 0.140 |
Why?
|
| Teaching | 1 | 2018 | 59 | 0.140 |
Why?
|
| Opioid-Related Disorders | 2 | 2013 | 195 | 0.140 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 139 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 4 | 2009 | 515 | 0.130 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1998 | 171 | 0.130 |
Why?
|
| HIV | 2 | 2007 | 100 | 0.120 |
Why?
|
| AIDS Dementia Complex | 2 | 2014 | 116 | 0.120 |
Why?
|
| Synaptophysin | 1 | 2014 | 6 | 0.110 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 21 | 0.110 |
Why?
|
| Space Perception | 1 | 2014 | 35 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2015 | 102 | 0.110 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2013 | 26 | 0.100 |
Why?
|
| Transcription Factor AP-1 | 1 | 2013 | 34 | 0.100 |
Why?
|
| Janus Kinases | 1 | 2013 | 23 | 0.100 |
Why?
|
| Maze Learning | 1 | 2014 | 113 | 0.100 |
Why?
|
| Humans | 15 | 2021 | 43102 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 105 | 0.100 |
Why?
|
| Glutamic Acid | 1 | 2014 | 131 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 98 | 0.100 |
Why?
|
| Brain Tissue Transplantation | 1 | 2012 | 4 | 0.100 |
Why?
|
| Virulence Factors | 1 | 2013 | 125 | 0.090 |
Why?
|
| Viral Load | 4 | 2007 | 348 | 0.090 |
Why?
|
| Endogenous Retroviruses | 1 | 2012 | 17 | 0.090 |
Why?
|
| Virus Activation | 1 | 2012 | 38 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 196 | 0.090 |
Why?
|
| Mutation | 3 | 2009 | 1177 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 299 | 0.090 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2012 | 113 | 0.090 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2007 | 201 | 0.090 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2011 | 54 | 0.090 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 15 | 0.080 |
Why?
|
| Interleukin-18 | 1 | 2010 | 17 | 0.080 |
Why?
|
| Interleukin-12 | 1 | 2010 | 46 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2011 | 165 | 0.080 |
Why?
|
| Sequence Alignment | 3 | 2009 | 272 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 934 | 0.080 |
Why?
|
| Motor Activity | 1 | 2012 | 437 | 0.080 |
Why?
|
| Anti-HIV Agents | 2 | 2004 | 486 | 0.080 |
Why?
|
| Retroviridae Proteins | 1 | 2009 | 7 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 436 | 0.070 |
Why?
|
| Research Personnel | 2 | 2021 | 206 | 0.070 |
Why?
|
| Oxidants | 1 | 2007 | 42 | 0.070 |
Why?
|
| Female | 5 | 2021 | 24698 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2006 | 430 | 0.060 |
Why?
|
| Reassortant Viruses | 1 | 2006 | 11 | 0.060 |
Why?
|
| Models, Animal | 1 | 2006 | 151 | 0.060 |
Why?
|
| Point Mutation | 1 | 2006 | 98 | 0.060 |
Why?
|
| Amino Acids | 1 | 2006 | 148 | 0.060 |
Why?
|
| Gene Products, tat | 1 | 2005 | 36 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2006 | 123 | 0.060 |
Why?
|
| Retroviruses, Simian | 1 | 2005 | 3 | 0.060 |
Why?
|
| Exons | 1 | 2005 | 92 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 238 | 0.060 |
Why?
|
| Puerto Rico | 2 | 2015 | 1413 | 0.060 |
Why?
|
| Anxiety | 1 | 2012 | 874 | 0.050 |
Why?
|
| Child | 2 | 2018 | 3443 | 0.050 |
Why?
|
| Antioxidants | 1 | 2007 | 443 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2003 | 115 | 0.050 |
Why?
|
| Alcoholism | 1 | 2005 | 305 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2007 | 1003 | 0.040 |
Why?
|
| Maryland | 1 | 2021 | 66 | 0.040 |
Why?
|
| United States | 2 | 2019 | 5205 | 0.040 |
Why?
|
| Alkylation | 1 | 2000 | 11 | 0.040 |
Why?
|
| Hydroxyl Radical | 1 | 2000 | 14 | 0.040 |
Why?
|
| Base Sequence | 2 | 1998 | 983 | 0.040 |
Why?
|
| RNA, Viral | 3 | 2005 | 321 | 0.040 |
Why?
|
| Job Description | 1 | 2018 | 6 | 0.040 |
Why?
|
| Cell Line | 2 | 2013 | 1410 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2019 | 89 | 0.040 |
Why?
|
| Models, Educational | 1 | 2018 | 46 | 0.040 |
Why?
|
| Binding Sites | 1 | 2000 | 671 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 652 | 0.030 |
Why?
|
| Career Choice | 1 | 2018 | 52 | 0.030 |
Why?
|
| Protein Folding | 1 | 1998 | 123 | 0.030 |
Why?
|
| Cultural Diversity | 1 | 2019 | 193 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2018 | 359 | 0.030 |
Why?
|
| Protein Binding | 1 | 2000 | 1082 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1997 | 127 | 0.030 |
Why?
|
| Curriculum | 1 | 2018 | 318 | 0.030 |
Why?
|
| School Admission Criteria | 1 | 2015 | 10 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 32 | 0.030 |
Why?
|
| Genes, pol | 2 | 2004 | 15 | 0.030 |
Why?
|
| HIV Protease | 2 | 2004 | 23 | 0.030 |
Why?
|
| HIV Reverse Transcriptase | 2 | 2004 | 35 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 195 | 0.030 |
Why?
|
| Vagina | 2 | 2004 | 89 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2013 | 368 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2012 | 87 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2019 | 719 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2011 | 36 | 0.020 |
Why?
|
| Fetus | 1 | 2011 | 101 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 518 | 0.020 |
Why?
|
| Genes, env | 1 | 2009 | 13 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 2009 | 27 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2009 | 141 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 201 | 0.020 |
Why?
|
| Adult | 3 | 2015 | 13872 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2007 | 42 | 0.020 |
Why?
|
| Genotype | 1 | 2009 | 800 | 0.020 |
Why?
|
| Catalase | 1 | 2007 | 110 | 0.020 |
Why?
|
| Phenotype | 1 | 2009 | 780 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 158 | 0.020 |
Why?
|
| CD4-CD8 Ratio | 1 | 2005 | 29 | 0.010 |
Why?
|
| Candidiasis, Oral | 1 | 2004 | 24 | 0.010 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2004 | 44 | 0.010 |
Why?
|
| Genes, Viral | 1 | 2004 | 61 | 0.010 |
Why?
|
| Disease Transmission, Infectious | 1 | 2004 | 30 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 2157 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2005 | 184 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 135 | 0.010 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2004 | 74 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 5080 | 0.010 |
Why?
|
| Epitopes | 1 | 2004 | 157 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2005 | 279 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2004 | 229 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2004 | 311 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 6644 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 1857 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 12222 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1997 | 37 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1997 | 93 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1997 | 206 | 0.010 |
Why?
|